Filling the need for trusted information on national health issues…

Trending on kff King v. Burwell Medicaid Expansion Health Spending

Kaiser Daily Global Health Policy ReportClinical Research/R&D Search Results « » The Henry J. Kaiser Family Foundation

Clinical Research/R&D

  • your selections
Clear Search

Filter Results

date

Tags

  • results
People Diagnosed With HIV Should Begin Treatment Immediately, Study Shows

News outlets report on findings from the START trial, which show early treatment following HIV diagnosis provides greater benefits than postponing therapy. CQ Roll Call: Fauci Urges Early Start for HIV Treatment Based on New Study Findings “Results from a global study reinforce a United States policy of urging people…

GHTC Blog Post Discusses U.S., European Efforts To Address Drug Resistance, Speed Treatment Approvals

Global Health Technology Coalition’s “Breakthroughs”: Research Roundup: U.S. and European efforts to address growing antimicrobial resistance and legislation to advance medical breakthroughs Kat Kelley, GHTC’s senior program assistant, discusses efforts made by the U.S. and European Parliament to address the threat of antimicrobial resistance, as well as “a bill intended…

Xpert TB Test More Effective Than Traditional Detection Methods, Study Shows

Center for Global Health Policy’s “Science Speaks”: Large-scale study underscores value of routine Xpert testing on TB, MDR-TB case finding Antigone Barton, senior editor and writer of “Science Speaks,” discusses the findings of a recently published study conducted in India showing the Xpert molecular TB test is more effective than…

The Guardian Profiles Africa Centre For Health And Population Studies

The Guardian: Africa’s health center at the frontline of HIV research “The Africa Centre for Health and Population Studies sits in the HIV capital of the world. The sleek modern building, rising out of an otherwise rustic setting near Mtubatuba in South Africa, attracts world-class researchers looking to wage war…

Investment In HIV/AIDS Vaccine R&D Must Be Scaled Up

Global Health Technology Coalition’s “Breakthroughs”: Four reasons now is the time to ramp up investment in HIV/AIDS vaccine R&D Kat Kelley, GHTC’s senior program assistant, reports from a recent briefing on Capitol Hill that “convened leaders in the field to discuss the state of HIV/AIDS vaccine research and development (R&D).…

Ebola Outbreak Serves As ‘Wake-Up Call’ To Boost R&D, Prepare For Next Outbreak

Scientific American: After Ebola, a Blueprint Emerges to Jump-Start R&D Marie-Paule Kieny, WHO assistant director general for health systems and innovation “…The Ebola epidemic in West Africa has been called a wake-up call for so many reasons. … From where I sit in Geneva, the response by the global health…

Social Costs Of Diseases Must Be Considered When Debating Costs Of Drug R&D

U.S. News & World Report: The True Cost of Costly Drug Development Paul Howard, senior fellow and director of the Manhattan Institute’s Center for Medical Progress, and Yevgeniy Feyman, a fellow and deputy director of the Center for Medical Progress “…Focusing on the development costs, or even drug prices, without…

UNAIDS Renews Call For International Commitment To Develop HIV Vaccine

U.N. News Centre: U.N. agency calls for renewed global commitment to develop effective HIV vaccine “To mark HIV Vaccine Awareness Day, the Joint United Nations Programme on HIV/AIDS, or UNAIDS, has renewed its call for a sustained worldwide commitment to finding an effective HIV vaccine. Steadfast in leaving nobody behind…

Cuts To R&D Funding May Threaten Progress Toward HIV Vaccine, Panelists Say

Center for Global Health Policy’s “Science Speaks”: Budget cuts threaten HIV vaccine development, say experts Rabita Aziz, policy research coordinator for the Center for Global Health Policy, reports from an HIV Vaccine Awareness Day event that took place on Monday and hosted by AVAC, IAVI, and the Bill & Melinda…